MILWAUKEE, Oct. 23, 2015 /PRNewswire/ -- Dohmen Life Science Services (DLSS) Senior Vice President Terry Dagnon, M.S., will participate in a panel discussion, "Cell and Gene Therapy: Experiences from Regulatory Processes in US and EU," at the 2015 Regulatory Convergence Conference presented by the Regulatory Affairs Professional Society (RAPS) to be held Monday October 26 at the Baltimore Convention Center in downtown Baltimore.
"Our DLSS quality and regulatory teams are currently working with a large number of tissue, cell therapy, and biologics companies. We are excited to share our broad experience in this growing segment of our industry. As these technologies, legislation and companion regulations continue to evolve it is important to interact with our peers at RAPS," stated Mr. Dagnon.
The panel of US and European experts who represent both product development and regulatory agency perspectives will discuss best practices for clinical trial applications and development.
The Regulatory Convergence is the premier event for regulatory professionals working in the medical device, pharmaceutical and biotech industries.
Headquartered in Milwaukee, Wisconsin, Dohmen has been finding ways to create an efficient, effective and easy-to-use healthcare experience since 1858; first as an apothecary, then as a manufacturer, later as a wholesaler and today by supporting hundreds of companies ranging from start-up to Fortune 500 with innovative services and technology that improve human health. Learn more about the Dohmen family of companies at www.dohmen.com.
SOURCE Dohmen Life Science Services